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Locating systematic reviews of
test accuracy studies: How five
specialist review databases
measure up
Sue E. Bayliss, Clare Davenport
University of Birmingham
Objectives: The aim of this study was to examine location of systematic reviews of test
accuracy in five specialist review databases: York CRD’s DARE and HTA databases,
Medion (University of Maastricht), C-EBLM (International Federation of Clinical
Chemistry), and the ARIF in-house database (University of Birmingham).
Methods: Searches were limited to the period 1996–2006. Test accuracy reviews were
located using in-house diagnostic search filters and with help from database producers
where databases were not confined to test accuracy reviews. References were coded
according to disease area, review purpose, and test application. Ease of use, volume,
overlap, and content of databases was noted.
Results: A large degree of overlap existed between databases. Medion contained the
largest number (n = 672) and the largest number of unique (n = 328) test accuracy
references. A combination of three databases identified only 76% of test reviews. All
databases were rated as easy to search but varied with respect to timeliness and
compatibility with reference management software. Most reviews evaluated test accuracy
(85%) but the HTA database had a larger proportion of cost-effectiveness and screening
reviews and C-EBLM more reviews addressing early test development. Most reviews were
conducted in secondary care settings.
Conclusions: Specialist review databases offer an essential addition to general
bibliographic databases where application of diagnostic method filters can compromise
search sensitivity. Important differences exist between databases in terms of ease of use
and content. Our findings raise the question whether the current balance of research
setting, in particular the predominance of research on tests used in secondary care,
matches the needs of decision makers.
Keywords: Information storage and retrieval; Databases, bibliographic; Technology
assessment; Systematic reviews; Tests, diagnostic
There has been a growth in the volume of primary research
concerned with testing over recent years, reflected in the
number of systematic reviews in the area. The analysis of all
systematic reviews indexed in MEDLINE in 2004 by Moher
Many thanks to Julie Glanville (CRD University of York), Joseph Watine
(IFCC C-EBLM), and Berna Schouten, MEDION for their help during the
conduct of the research; and to Julie Glanville and Kath Wright (CRD),
Joseph Watine (IFCC), Chris Hyde, and Anne Fry-Smith (University of
Birmingham) for comments on earlier drafts. Source of funding: None.
et al. (15) estimated 2,500 systematic reviews were being
published annually. Although systematic reviews concerned
with test performance represent a small proportion of re-
views overall (approximately 8 percent) (15), their number
has increased substantially over the past decade (7;12;16)
substantiated by analysis of the five databases in our own
study (see Supplementary Figure 1, which can be viewed
online at www.journals.cambridge.org/thc).
Systematic reviews are an important resource for sum-
marizing existing knowledge about test accuracy from
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Figure 1. Unique References According to Database.
primary studies either for the busy practitioner trying to
find a review to help answer a clinical question or for the
reviewer wanting to assess the available evidence about a
test. Databases of systematic reviews of test accuracy are
also an important resource when undertaking methodologi-
cal research as they can provide a representative or selective
sample of reviews.
However, it is well-documented that using methodolog-
ical search filters with general bibliographic databases to lo-
cate studies of test accuracy is at best unreliable (10;14;17).
This would suggest that specialist review databases and in
particular those devoted to reviews of test accuracy provide
an alternative and possibly more reliable means of efficiently
accessing these studies.
AIMS AND OBJECTIVES
To evaluate how five specialist systematic review databases
perform with respect to different research requirements con-
cerned with test accuracy in terms of (i) Overlap between
databases, (ii) Utility (flexibility of searching, accessibility,
compatibility with reference management software) and cur-
rency, (iii) Epidemiology of systematic reviews contained in
the databases.
METHODS
Our objective was to establish as large a repository of sys-
tematic reviews of test accuracy as possible for the purposes
of a piece of methodological research. This offered the op-
portunity to examine the databases from which the reviews
were sourced in detail and to describe the epidemiology of
reviews contained in these databases.
The five chosen databases all claim to contain systematic
reviews as opposed to narrative reviews and commentaries.
Systematic reviews have been defined as reviews that use
“systematic and explicit methods to identify, select and crit-
ically appraise relevant primary research, and to extract and
analyze data from studies that are included in the review” (9).
The extent to which reviews contained in included databases
met these criteria was not ascertained.
The specialist reviews databases included were the fol-
lowing (date of inception in brackets): Health technology
assessment (HTA) database by means of Cochrane Library
(1998) (2); Database of Abstracts of Reviews of Effects
(DARE) by means of Cochrane Library (1994) (2); Medion
database of diagnostic reviews (University of Maastricht)
(1994) (13); International Federation of Clinical Chemists
Committee of Evidence Based Laboratory Medicine (IFCC
C-EBLM) reviews database (established 1996 as personal
Web site of Wytze Oosterhuis, publicly available on the IFCC
Web site in 2004) (1); ARIF (Aggressive Research Intelli-
gence Facility, University of Birmingham) in-house reviews
database (1996).
Of these specialist review databases, Medion and C-
EBLM are devoted solely to systematic reviews of tests,
whereas only a percentage of the other much larger gen-
eral systematic reviews databases comprise reviews of tests
(around 6 percent of HTA and 10–11 percent of DARE and
ARIF). Despite the fact that at the time the research was
conducted the ARIF in-house database was not accessible to
the public it was chosen for inclusion on the basis that its
characteristics are well known to the authors and, therefore,
could be used as a point of reference for considering the other
databases.
Optimal search strategies such as those created by
Haynes and Wilczynski (6) for use with general bibliographic
databases do not exist for use with DARE and HTA so a prag-
matic filter had to be created to retrieve as many test accuracy
reviews as possible, given that these reviews are not denoted
by any special indexing on these two databases. The ARIF
database tags diagnostic and screening reviews as such on
inclusion so these were easily retrieved.
Searches for all systematic reviews of test accuracy in
each database were carried out in January 2007 for the period
1996–2006. Ease of use of databases (see Table 1) was noted.
Given the number of references likely to be retrieved and the
difficulties caused by poor indexing of systematic reviews of
test accuracy already described, searches of HTA and DARE
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Table 1. Finding Systematic Reviews of Test Accuracy: Comparing Features of Specialist Review Databases
Medion DARE HTA IFCC’s C-EBLM ARIF
Owned by University of
Maastricht
University of York
CRD
INAHTA/
University of York
CRD
International
Federation of
Clinical
Chemistry
C-EBLM
Committee
ARIF University of
Birmingham
Document source Majority sourced
from MEDLINE,
some from other
sources
Handsearching,
scanning
databases(list on
Web site)
Scanning Web sites,
INAHTA project
submissions every
6 months
Searching
MEDLINE and
other resources
using filters,
contact with
experts, HTA
sites
Scanning and
alerting services
Study type Systematic reviews.
Separate
methodology and
genetics
databases
Systematic reviews Systematic reviews,
other types of
health technology
assessment
Systematic reviews Systematic reviews.
Separate
methodology
database
Overall size of
databases (Jan
2007)
1500 0verall: 796 –
reviews, 597 –
methods, 119-
genetics
4539 6175 555 8670
Dataset Au, ti, source Au, ti, source Au, ti, source Au, ti, source Au, ti, source
Abstract
√ √ √ √
×
Textword search
√ √ √
×
√
Indexed by Keywords IPCP
codes
MeSH MeSH Keywords Keywords
Links to text ×
√ √
× ×
Ease of use
√ √ √ √ √
Advanced search
√ √ √
× ×
Quality assured ×
√
× × ×
Updating Periodic Monthly Monthly Twice per year Weekly
Gives no of hits
√ √ √ √ √
Compatible for
reference
management
software
x
√ √
×
√
Sort facility
√ √ √ √
×
Disadvantages Web site is
sometimes
inaccessible
because of
technical
problems No help
facility
Cannot search for
test accuracy
reviews separately
at present
Test accuracy
studies not
identified
separately as such
Database not easy
to locate from
IFCC Web site.
Potential
language bias
(English reviews
only)
Currently only
available in-house
(plans to make it
accessible via
ARIF Web site).
Advantages First established
specialist
database of
reviews of test
accuracy. Most
unique references
Special index field
“Reference
standard against
which new test
was compared” to
allow for detailed
indexing of
reviews of test
accuracy studies.
International focus.
Good resource for
reviews concerned
with screening
Special focus on
laboratory
medicine Well
indexed. Lot of
unique references
Most current as
updated on weekly
basis Separate
subset of
diagnostic reviews
easy to locate
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Figure 2. Percentage of each database accounted for by disease category.
were limited to MeSH index terms to make them as specific
as possible. To select the most appropriate MeSH terms for
our filter an analysis by Leeflang et al. (10) which compared
the performance of twelve validated diagnostic search filters
was consulted. We selected the most frequently used MeSH
term in these filters: “Sensitivity and Specificity” (exp) (92
percent of filters) to which the term “Mass Screening” was
added to capture a variety of testing applications. The MeSH
term “Diagnosis” (exp) or text word “diagnostic” greatly re-
duced the specificity of the searches and so were not used.
We sought to verify the performance of our filter with the
help of in-house searches of DARE and HTA performed by
database producers CRD (Centre for Reviews and Dissem-
ination, University of York). Diagnostic reviews in DARE
are coded in-house but searching in this way is not currently
available on the general database interface. A search of the
HTA database was undertaken by database producers using
their preferred terms. The ARIF database was searched on
the subset diagnosis as well as the text word screening and
false positive hits were identified by scrutiny of retrieved
records (see Supplementary Table 1, which can be viewed at
www.journals.cambridge.org/thc, for terms used in filters).
Scrutiny of retrieved records for false positive hits (re-
views not concerned with diagnosis) also allowed inves-
tigation of the specificity of the filter (see flow of refer-
ences Supplementary Figure 2, which can be viewed at
www.journals.cambridge.org/thc). All records for the rele-
vant period in the specialist diagnostic reviews databases,
Medion and C-EBLM, were included. Reference Manager v
11 for Windows was used to store downloaded records from
Figure 3. Percentage of each database according to review purpose.
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Figure 4. Percenntage of individual databases according to test application.
DARE, HTA and ARIF. C-EBLM and Medion are not com-
patible with Reference Manager at this time and citations
from these databases were, therefore, added manually.
Exclusion Criteria
The focus for the methodological review was systematic re-
views concerned with assessment of test accuracy, either in
isolation or as part of a broader evaluation of tests. Thus
our search aimed to identify systematic reviews concerned
with evaluation of test accuracy, test effectiveness, test cost-
effectiveness, and test accuracy methodological reviews. Pa-
pers were excluded only if they were not concerned with test
evaluation or they were not reviews.
Coding of References
References were tagged according to their database source.
In addition epidemiological characteristics of test accuracy
reviews were noted based on review title. The disease topic
area or areas the review was addressing was noted. To ensure
consistency a pro-forma was used as in some instances a
topic could be placed in more than one category. For example
tuberculosis was consistently placed in “infectious diseases”
rather than “respiratory”. Further detail of the method of
classification is available from the authors on request.
The purpose of the review was coded as “test accu-
racy” only, “costs” of testing, “effectiveness” of testing,
“cost-effectiveness” of testing, “methodological” reviews or
“other”, (concerned with test acceptability; descriptive ac-
counts of promising disease markers, tests and test strategies;
consequences of tests error; organization of testing programs;
morphological studies; methods of test execution). Test ac-
curacy reviews were further subdivided into those concerned
with estimation of test accuracy of single tests or with esti-
mation of accuracy of more than one test.
The clinical setting in which the test was being evaluated
for use was noted. Test setting was defined as the likely origin
of patients to be tested and not the setting in which the test
was to be applied. Thus for example ultrasound examination
and X-rays could be initiated and acted on in primary care
but the tests themselves would be likely to take place in a sec-
ondary care setting. Reviews were coded as being concerned
with tests to be used in a screening context (encompassing
population based and targeted screening programs), over the
counter, in the community, primary care, secondary care or
for use in multiple settings.
The search facility in Reference Manager was used to
identify yield of references by single database and database
combinations and to map characteristics of test accuracy re-
views contained in the databases.
RESULTS
Performance of Pragmatic Search Filter in
General Specialist Review Databases
The flow of references is illustrated in Supplementary Fig-
ure 1 (www.journals.cambridge.org/thc). For those databases
with MeSH search facilities (DARE and HTA) the pragmatic
filter performed variably for identification of reviews con-
cerned with testing. There were 89 false positive hits for
DARE (19 percent of DARE hits) and 9 in the HTA database
(3 percent of HTA hits). The number of false positives gen-
erated by searching the ARIF in-house database using the
terms diagnosis and screening was low; n = 13 (3 percent).
In the HTA database only 16 (5 percent) of hits were not
reviews. In the ARIF database 2 (<1 percent) of hits had
been wrongly added to the database as reviews when in fact
they were primary research (mostly case series).
Our pragmatic filter on the DARE database identified
72 percent of test accuracy reviews identified by DARE
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producers. Our search yielded 383 relevant references for
period 1996–2006 of which 24 percent (93) were unique
to DARE. The DARE in-house search yielded 542 tagged
references for the same period and we, therefore, estimated
130 of these references would be unique to DARE (24 per-
cent of 542). Both estimates are important; our estimate of
383 is likely to approximate to the yield from a search of
DARE on the public interface whilst the database producer
estimate is a more valid representation of the number of test
accuracy reviews within DARE. Reviews identified by in-
house searching of the HTA database yielded fewer hits than
searches using our pragmatic filter (HTA in-house search n =
172 and our search n = 333 between 1996 and 2006). For
the purposes of calculating yield of relevant references for
single databases and across multiple databases we, therefore,
used our estimate of 333.
Duplication across Databases
Yield of Test Accuracy Reviews by Single
Databases. One record from Medion (a letter) had been
erroneously included in the database. All of the records in the
C-EBLM databases were reviews. Both the Medion database
and the C-EBLM database contained references not con-
cerned with evaluation of test accuracy (1 percent of Medion
records and 9 percent of C-EBLM records), all investigating
putative causal associations between laboratory-based mark-
ers and disease.
If searches were restricted to a single database and
where necessary use of a pragmatic search filter, the largest
number of test accuracy reviews would be identified by us-
ing Medion, followed by the ARIF in-house database, C-
EBLM, DARE and finally HTA (see Supplementary Fig-
ure 2, at www.journals.cambridge.org/thc). Using the DARE
database producer estimate revises the proportion of reviews
that would be identified by DARE to 30 percent.
Unique References by Database. After removing
reviews not concerned with diagnosis and primary research
papers Medion had the most unique test accuracy review
references (references not contained in any other database)
(n = 328) followed by the HTA database (n = 264), C-
EBLM database (n = 248) and the ARIF database (n = 232).
DARE had the least number of unique test accuracy review
references (n = 93). Using the DARE database producer
estimate would increase the number of references unique to
the DARE database to 130 but would not change its rank
order.
Yield of Test Accuracy Reviews from Searches
of Database Combinations. Supplementary Table 2 on-
line (www.journals.cambridge.org/thc) documents the yield
of reviews for combinations of 2 and 3 databases. A combina-
tion of three publicly available databases (C-EBLM, Medion
and HTA) at best yielded 1,232 references (76 percent of the
total). A combination of Medion and the HTA database or
Medion and C-EBLM yielded 948 and 952 references (59
percent of the total). The lowest yield of references was ob-
tained by a combination of the DARE and HTA databases
(561; 35 percent) but it must be noted that this low yield may
be explained by the fact that DARE is a selective, quality
assured resource.
Content of Databases: Characteristics of
Indexed Test Accuracy Reviews
This analysis is based on the content of the 1,620 test ac-
curacy reviews identified by our search filter in DARE and
HTA, those appropriately tagged in the ARIF database and
all reviews contained in Medion and C-EBLM (see Supple-
mentary Figure 2, at www.journals.cambridge.org/thc) for
the period 1996–2006. Description of review characteristics
was based on review title.
Disease Topic Area. Testing in the disease area of
obstetrics and gynecology accounts for between 8 percent
and 18 percent, median 13 percent of citations (18 percent
overall). Cardiovascular disease (“cardio”) and gastrointesti-
nal disease (“GI”) were also prominent accounting for be-
tween 9 percent and 15 percent of citations, (15 percent
overall). In addition ophthalmology was prominent in the
Medion database (11 percent citations). The high proportion
of reviews concerned with infectious disease (“Infec”) and
hematology (“Haem”) in the C-EBLM database is proba-
bly a reflection of the laboratory emphasis of this database.
The relatively high proportion of genetic testing reviews in
the HTA database (12 percent) may be a reflection of the
priority of this topic area as an emerging health technology
(19). It should be noted that the Medion database has a sepa-
rate section devoted solely to reviews concerned with genetic
testing which was not included in our analysis. The number
of reviews in the Medion genetics section over our period
of study was 119. This would increase the proportion of ge-
netics reviews in Medion to be close to 20 percent of the
total across the general reviews and genetics sections, com-
pared with the 1 percent indicated in Supplementary Fig-
ure 2 (www.journals.cambridge.org/thc).
Review Purpose. With the exception of the HTA
database most reviews were concerned solely with the es-
timation of test accuracy (66–81 percent across 4 databases;
85 percent of all citations). This is not an unexpected finding
as in the context of health technology assessment evaluation
of the acceptability, effectiveness and cost-effectiveness of
tests is important. Indeed the HTA database had the high-
est proportion of reviews concerned with the evaluation of
cost-effectiveness of tests (11 percent). Our classification did
not allow discrimination between accuracy being evaluated
at different stages of test development. It was evident from
scrutiny of titles and abstracts that the C-EBLM database con-
tained a larger proportion of reviews concerned with early
test development using a case control design. This was in
contrast to other databases where the predominant type of
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test accuracy study was in a clinical setting, (screening, di-
agnosis, prognosis or disease monitoring) (5;18).
Relatively few test accuracy reviews were concerned
with evaluation of effectiveness alone, costs alone, or as part
of the review process highlighted an area of methodology.
The proportion of reviews for which the purpose was unclear
was high (16–64 percent across 5 databases and 38 percent
overall) and it is unknown what impact the accurate coding of
this subset would have on the distribution of review purpose
across databases.
Clinical Setting in which Tests Are Applied.
There was a striking preponderance of tests evaluated in
secondary care and screening contexts across all databases.
Overall only 4 percent of reviews evaluated tests for use in
primary care (1–6 percent across individual databases). Sec-
ondary care and screening would still dominate as research
settings even if all of the reviews coded as “unclear setting”
were in fact evaluations of tests in primary care.
Features of Databases
A comparison of the different features of the five databases
is presented in Table 1. Whereas the ARIF database is least
sophisticated in terms of searching and content of individual
records, it is the most up-to-date of the five and test accuracy
reviews are easily retrieved as they are tagged on inclusion.
However, although there are plans to make it accessible by
means of the ARIF website, currently this database is not
accessible to the public. DARE and HTA offer a much more
sophisticated product in terms of search and retrieval but
test accuracy reviews are not coded separately. DARE is
the only database to contain abstracts of reviews that have
been quality-assessed, containing a summary of the review
together with a critical commentary about its overall quality
and as a result of this is a selective rather than a comprehen-
sive resource. Medion is the longest established specialist
database devoted to test accuracy reviews and is user-friendly
as well as comprehensive with separate smaller databases de-
voted solely to reviews of genetic tests and methodological
papers. The IFCC’s C-EBLM database differs quite markedly
in content from the other databases with its emphasis on lab-
oratory tests and is a well indexed supplementary resource,
although it is updated only twice per year.
FUTURE DEVELOPMENTS
The Cochrane Diagnostic Test Register Group (DTRG) aims
to “develop a clean and comprehensive register of reports
of diagnostic test accuracy studies” (3;4). Their register
will contain primary studies concerned with test accuracy
in screening or diagnostic contexts and will be the equiva-
lent of Cochrane’s CENTRAL trials register. The DTRG will
also support review groups in the production of diagnostic
reviews, the first pilot review is likely to be published in
2008. The reviews will be added to the Cochrane Database
of Systematic Reviews (CDSR) and flagged as diagnostic
reviews. The development of the register is currently in its
early stages and although it will lead to improved review
methodology, the number of reviews will grow slowly. In
the meantime those wishing to access up to date and com-
prehensive secondary research evidence concerning testing
will need to rely on the sources outlined above or apply
methodological filters for retrieving test accuracy reviews to
bibliographic databases such as MEDLINE.
SUMMARY
Specialist review databases are an important resource in
terms of providing an easily accessible and reliable means
of locating the increasing number of systematic reviews con-
cerned with testing.
Specialist review databases that are not confined to re-
views of test accuracy (DARE, HTA, ARIF) may be searched
quite easily for a specific type of test but when a large number
of reviews of any type of test are required for methodological
purposes then some sort of search filter must be applied. This
research was concerned with identifying as large a number
of systematic reviews of test accuracy in DARE and HTA as
possible in a short space of time. Our experience suggests
that one size does not fit all and in particular a range of terms
reflecting a variety of potential applications of tests (for ex-
ample screening and diagnosis) and test accuracy outcomes
in common use, such as sensitivity and specificity, should be
used.
There is a large degree of overlap between databases
which is an important finding for those conducting research
where a comprehensive sample of reviews is not the aim.
The Medion database yielded the largest number of unique
references and appeared to contain a representative sample of
reviews in terms of disease area, test application and review
purpose. However, timeliness and reliability are potential
disadvantages of the Medion database. The DARE database
yielded the lowest number of unique references but has the
advantage of full abstracts and advanced search facilities. The
DARE database is also quality assured. However, the quality
of systematic reviews of test accuracy is generally poor and
is an area in development (16), therefore, the extent to which
quality assessment might compromise yield is unknown.
With respect to review purpose, the C-EBLM database
appears to focus on reviews concerned with early test devel-
opment whilst HTA and DARE have a larger proportion of
reviews concerned with evaluating the effectiveness of tests.
The HTA database also has a relatively high proportion of re-
views concerned with the evaluation of the cost-effectiveness
of tests. NHS EED which contains over 50,000 abstracts of
quality assessed economic evaluations is another obvious re-
source for reviewers concerned with cost-effectiveness but
was not included in this analysis (2).
With respect to test application, all databases had a
high proportion of reviews concerned with tests applied in
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a screening context, in particular the HTA database. This is
not a surprising finding when one considers the costs and
risks associated with population-based screening and the ex-
istence of well developed systems for evaluating screening
programs. However, evaluation of tests for use in diagnosis
in secondary care also predominated across all databases.
This may be a reflection of the relatively higher unit cost
of many tests used in secondary care. However, the volume
of tests conducted in primary care is high and continues to
increase (11), probably in part facilitated by the move of
chronic disease monitoring from secondary to primary care
(8). Our research suggests that there is a need to examine
the balance of test accuracy research being conducted across
care settings.
With respect to the quality of reviews contained in
databases DARE is the only database that is quality assured.
Whilst this is often an advantage it may compromise gener-
alizability, for example where the purpose of research is to
reflect current practice.
For researchers requiring comprehensiveness a combi-
nation of three databases at best identified between 69 per-
cent and 76 percent of citations (see Supplementary Table 2,
available online at www.journals.cambridge.org/thc). In this
context it is important to note that at present Medion and
C-EBLM cannot be downloaded into reference management
software which has implications for workload.
An algorithm suggesting suitability of databases for dif-
ferent search requirements may be viewed online as Supple-
mentary Table 3 (www.journals.cambridge.org/thc).
LIMITATIONS OF THE STUDY AND
IMPLICATIONS FOR FURTHER RESEARCH
Our pragmatic filters (see Supplementary Table 1, available
online at www.journals.cambridge.org/thc) may have missed
relevant citations in databases where the content was not
solely concerned with testing. The main impact of any omis-
sions would be to underestimate the contribution of databases
in terms of yield in our analysis although we cannot rule out
the possibility that a basic search would skew results toward
references of a certain content. The pragmatic filter appears
to have performed well in the HTA database although further
research would be needed to verify its performance com-
pared with other search strategies. It did not perform so well
in the DARE database and until coded access to test accuracy
reviews is made possible on the public interface of DARE, a
more sophisticated search strategy than the one we adopted
should probably be advocated.
For pragmatic reasons we coded review characteristics
based on the review title alone and as a result errors in clas-
sification may have occurred; many reviews were coded as
having an unclear setting or review purpose. However, this is
an important finding in itself. Further research is needed to
identify whether lack of clarity in review titles is a reflection
of lack of clarity in review methods and/or reporting.
The purpose of our research was to identify reviews con-
cerned in whole or in part with test accuracy. It is likely that
reviews concerned with any type of test evaluation would
include the terms sensitivity, specificity or screening but our
search strategy may have missed reviews where the focus was
on test costs, test effectiveness and test cost-effectiveness.
Our analysis did not include the NHS EED database or the
CDSR database. CDSR does not claim to include systematic
reviews of test accuracy studies although our search filter
identified 16 relevant hits from CDSR between 1996 and
2006 concerned with various aspects of screening. Using
our filter in NHS EED between 1996 and 2006 identified
in excess of 800 hits. Without further research we can-
not comment on the relevance of these citations or their
content, but NHS EED represents an important resource
for those interested in cost-effectiveness issues applied to
testing (2).
CONCLUSIONS
There is a large and increasing number of reviews of test ac-
curacy. Given the widely held concern that applying method-
ological search filters to capture test accuracy research does
not provide adequate sensitivity for systematic review pur-
poses, specialist review databases are an important resource
for identifying such reviews, although comprehensiveness is
likely to require a search across multiple databases. Medion
and C-EBLM offer an efficient option for researchers and
reviewers. Important differences between the specialist re-
views databases should be borne in mind when choosing a
resource and dependent on the purpose of research. Reviews
contained in the specialist databases scrutinized are largely
concerned with estimation of test accuracy and with appli-
cation of tests in secondary care or for screening at present.
There is a paucity of reviews concerned with the application
of tests for diagnosis in primary care.
Resources such as these can change rapidly so a watch-
ing brief is important when searching this area. Since writ-
ing this article, two developments of note have taken place.
From the end of July 2008 the ARIF database will be ac-
cessible to the public by means of the ARIF Web site
at http://www.arif.bham.ac.uk/. Regrettably the C-EBLM
database is no longer accessible by means of the IFCC Web
site as there is uncertainty over its future, but at present those,
who are interested can request a copy of the database in Excel
format from Joseph Watine (j.watine@ch-rodez.fr).
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